78 followers
8,047 followers
My take on $LLY ODAC: 1) Agree that $LLY needs a new trial w/ OS endpoint. 2) Amused that FDA was so stuck on race demographics when anti-PD-1 response is unpredictable even for patients of the same race https://t.co/9F8FyYqORu
2,376 followers
@DoctorTro @PhRMA @cochranecollab @VPrasadMDMPH @MDAndersonNews Here’s your evidence, by the way. https://t.co/F5qj8SqKwX https://t.co/Z0JLLyrdXD https://t.co/jTzbol5kJI https://t.co/z9DXUl40CC https://t.co/XZXXKojkTe https://t.co/ZVGv3XUSIf https:
0 followers
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors. https://t.co/vfULiNfPHb